Teachers Advisors’s Immunic IMUX Stock Holding History

Teachers Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-99	Closed	-$271K	–	3029
2018 Q2	$271K	Buy	+99	New	+$229K	﹤0.01%	2905
2017 Q2	–	Sell	-116	Closed	-$186K	–	3145
2017 Q1	$186K	Hold	116	–	–	﹤0.01%	2888
2016 Q4	$202K	Hold	116	–	–	﹤0.01%	2906
2016 Q3	$284K	Buy	116 +12	+12%	+$29.6K	﹤0.01%	2734
2016 Q2	$258K	Hold	104	–	–	﹤0.01%	2761
2016 Q1	$377K	Buy	104 +18	+21%	+$62.5K	﹤0.01%	2501
2015 Q4	$398K	Buy	86 +15	+21%	+$49K	﹤0.01%	2537
2015 Q3	$115K	Buy	71 +7	+11%	+$35K	﹤0.01%	2997
2015 Q2	$542K	Buy	64 +41	+178%	+$391K	﹤0.01%	2483
2015 Q1	$232K	Buy	23 +5	+28%	+$46K	﹤0.01%	2826
2014 Q4	$183K	Hold	18	–	–	﹤0.01%	2931
2014 Q3	$150K	Hold	18	–	–	﹤0.01%	2977
2014 Q2	$200K	Buy	+18	New	+$126K	﹤0.01%	2932

Other funds holding IMUX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Teachers Advisors's IMUX Position: Q3 2018 in Review

Teachers Advisors sold out of Immunic (IMUX) in Q3 2018, closing a stake of 99 shares — an estimated $271K sold.

Teachers Advisors first reported a position in IMUX in Q2 2014 and held it in 13 quarters. The position peaked at $542K in Q2 2015. 54 funds tracked by Wall St. Rank hold IMUX as of Q3 2018.

Teachers Advisors reported no remaining Immunic position as of Q3 2018 after selling out during the quarter.
Teachers Advisors sold 99 Immunic shares in Q3 2018, an estimated $271K.
Teachers Advisors first reported a position in Immunic in Q2 2014 and held it in 13 quarters.
Teachers Advisors's Immunic position peaked at $542K in Q2 2015.
54 funds tracked by Wall St. Rank held Immunic as of Q3 2018.

Based on Teachers Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.